Thermo Fisher Scientific (NYSE: TMO)
You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Thermo Fisher Scientific Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Thermo Fisher Scientific Company Info
Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment is composed of a portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs and vaccines, as well as diagnosis of infection and disease. The Analytical Instruments segment offers instruments, consumables, software, and services that are used for a range of applications in the laboratory, on the production line, and in the field. The Specialty Diagnostics segment provides diagnostic test kits, reagents, culture media, instruments, and associated products used to increase the speed and accuracy of diagnoses. The Laboratory Products and Services segment is involved in providing everything needed for the laboratory, including a combination of self-manufactured and sourced products for customers in research, academic, government, industrial, and healthcare settings. The company was founded on October 11, 1960 and is headquartered in Waltham, MA.
News & Analysis
This lab equipment and services company has made shareholders much richer over the past five years.
These exchange-traded funds track companies in this biotech space.
These two companies are leaders in their industries, and they're relatively safe, too.
These two companies stand the test of time and can likely make their investors richer, too.
In uncertain times, resilient businesses can still thrive.
Can you count on these distributions to continue rising?
These stocks would have more than doubled your money in the past five years.
Valuation
Earnings Transcripts
TMO earnings call for the period ending June 30, 2023.
TMO earnings call for the period ending December 31, 2022.
TMO earnings call for the period ending September 30, 2022.
TMO earnings call for the period ending June 30, 2022.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.